Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial.
Crane
Paul K
PK
Doody
Rachelle S
RS
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy*; D015986:Confounding Factors, Epidemiologic; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D015588:Observer Variation; D010352:Patient Dropouts; D010880:Piperidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil